Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: A 12-year mean follow-up study

Acta Ophthalmologica

Volumn 91, Issue 4, 2013, Pages

  Kim, Martha ^a   Kim, Dong Myung ^a,b   Park, Ki Ho ^a,b   Kim, Tae Woo ^a,c   Jeoung, Jin Wook ^a,b   Kim, Seok Hwan ^a,d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

Author keywords

disease progression; intraocular pressure; normal tension glaucoma; topical drug administration

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBONATE DEHYDRATASE INHIBITOR; PROSTAGLANDIN DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTIC DISK; PRIORITY JOURNAL; RETINA NERVE CELL; RETROSPECTIVE STUDY; RISK FACTOR; TOPICAL TREATMENT; VISUAL FIELD;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; CARBONIC ANHYDRASE INHIBITORS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS, SYNTHETIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84878461330     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12082     Document Type: Article

References (35)

1. Ajtony C, Balla Z, Somoskeoy S, &, Kovacs B, (2007): Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by optical coherence tomography. Invest Ophthalmol Vis Sci 48: 258-263.
2. Aoyama A, Ishida K, Sawada A, &, Yamamoto T, (2010): Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma. Jpn J Ophthalmol 54: 117-123.
3. Araie M, Shirato S, Yamazaki Y, Matsumoto C, Kitazawa Y, &, Ohashi Y, (2012): Risk factors for progression of normal-tension glaucoma under beta-blocker monotherapy. Acta Ophthalmol 90: e337-e343.
4. Birch MK, Wishart PK, &, O'Donnell NP, (1995): Determining progressive visual field loss in serial Humphrey visual fields. Ophthalmology 102: 1227-1234; discussion 1234-1225.
5. Cheng JW, Cai JP, &, Wei RL, (2009): Meta-analysis of medical intervention for normal tension glaucoma. Ophthalmology 116: 1243-1249.
6. CNTGS (1998a): Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126: 487-497.
7. CNTGS (1998b): The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126: 498-505.
8. Copt RP, Thomas R, &, Mermoud A, (1999): Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol 117: 14-16.
9. Daugeliene L, Yamamoto T, &, Kitazawa Y, (1999): Risk factors for visual field damage progression in normal-tension glaucoma eyes. Graefes Arch Clin Exp Ophthalmol 237: 105-108.
10. Desai PV, &, Caprioli J, (2008): The treatment of normal-tension glaucoma. Prog Brain Res 173: 195-210.
11. Drance S, Anderson DR, &, Schulzer M, (2001): Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131: 699-708.
12. Heijl A, (2013): The times they are a-changin': time to change glaucoma management. Acta Ophthalmol 91: 92-99.
13. Ishida K, Yamamoto T, Sugiyama K, &, Kitazawa Y, (2000): Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol 129: 707-714.
14. Jonas JB, &, Xu L, (1993): Parapapillary chorioretinal atrophy in normal-pressure glaucoma. Am J Ophthalmol 115: 501-505.
15. Jonas JB, Sturmer J, Papastathopoulos KI, Meier-Gibbons F, &, Dichtl A, (1995): Optic disc size and optic nerve damage in normal pressure glaucoma. Br J Ophthalmol 79: 1102-1105.
16. Katz J, (2000): A comparison of the pattern- and total deviation-based Glaucoma Change Probability programs. Invest Ophthalmol Vis Sci 41: 1012-1016.
17. Kawano J, Tomidokoro A, Mayama C, Kunimatsu S, Tomita G, &, Araie M, (2006): Correlation between hemifield visual field damage and corresponding parapapillary atrophy in normal-tension glaucoma. Am J Ophthalmol 142: 40-45.
18. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, &, Komaroff E, (2003): Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121: 48-56.
19. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, &, Yang Z, (2007): Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114: 1965-1972.
20. Morad Y, Sharon E, Hefetz L, &, Nemet P, (1998): Corneal thickness and curvature in normal-tension glaucoma. Am J Ophthalmol 125: 164-168.
21. Nakagami T, Yamazaki Y, &, Hayamizu F, (2006): Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 50: 38-43.
22. Park KH, Tomita G, Liou SY, &, Kitazawa Y, (1996): Correlation between peripapillary atrophy and optic nerve damage in normal-tension glaucoma. Ophthalmology 103: 1899-1906.
23. Park SC, Lee DH, Lee HJ, &, Kee C, (2009): Risk factors for normal-tension glaucoma among subgroups of patients. Arch Ophthalmol 127: 1275-1283.
24. Perkins ES, &, Phelps CD, (1982): Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction. Arch Ophthalmol 100: 1464-1467.
25. Seong GJ, Rho SH, Kim CS, et al., (2009): Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea. J Ocul Pharmacol Ther 25: 91-96.
26. Shigeeda T, Tomidokoro A, Araie M, Koseki N, &, Yamamoto S, (2002): Long-term follow-up of visual field progression after trabeculectomy in progressive normal-tension glaucoma. Ophthalmology 109: 766-770.
27. Sohn SW, Song JS, &, Kee C, (2010): Influence of the extent of myopia on the progression of normal-tension glaucoma. Am J Ophthalmol 149: 831-838.
28. Stewart WC, Kolker AE, Sharpe ED, Day DG, Holmes KT, Leech JN, Johnson M, &, Cantrell JB, (2000): Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol 130: 274-279.
29. Sung KR, Lee S, Park SB, et al., (2009): Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci 50: 5266-5274.
30. Sung KR, Cho JW, Lee S, Yun SC, Choi J, Na JH, Lee Y, &, Kook M, (2011): Characteristics of Visual Field Progression in Medically Treated Normal-Tension Glaucoma Patients with Unstable Ocular Perfusion Pressure. Invest Ophthalmol Vis Sci 52: 737-743.
31. Suzuki Y, Iwase A, Araie M, et al., (2006): Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology 113: 1613-1617.
32. Tanna AP, &, Krupin T, (2009): Normal-Tension Glaucoma. In:, Shaarawy TM, Sherwood MB, Hitchings RA, &, Crowston JG, (eds). Glaucoma. Philadelphia: Saunders 361-366.
33. Tanna AP, Budenz DL, Bandi J, et al., (2012): Glaucoma progression analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma. Ophthalmology 119: 468-473.
34. Tomita G, Nyman K, Raitta C, &, Kawamura M, (1994): Interocular asymmetry of optic disc size and its relevance to visual field loss in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 232: 290-296.
35. Tuulonen A, &, Airaksinen PJ, (1992): Optic disc size in exfoliative, primary open angle, and low-tension glaucoma. Arch Ophthalmol 110: 211-213.